Skip to main content
Watch Insiders
Market intelligence
NRSNSector not reported

NeuroSense Therapeutics Ltd insider activity

In the last 90 days, 2 corporate insiders purchased $400,000 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$400,000
Corporate buyers
2
Latest transaction
Jun 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 16, 2026Alon Ben-NoonChief Executive OfficerOpen Market Purchase250,000$0.80$200,000
Jun 16, 2026Or EisenbergChief Financial OfficerOpen Market Purchase250,000$0.80$200,000